title: The role of glucocorticoids in endotoxin-mediated otitis media with effusion.
abstract: OBJECTIVE
  To understand the actions of glucocorticoids on the development and progression of endotoxin-mediated otitis media with effusion.
  
  
  METHODS
  The middle ears of 20 Sprague-Dawley rats were exposed to 35 microL of either 300-mOsm Krebs-Ringer solution (control; n = 5) or lipopolysaccharide, 1 mg/mL, dissolved in Krebs-Ringer solution (n = 15). Among the group that received lipopolysaccharide, 10 rats were randomly selected to receive dexamethasone (1 mg/kg intramuscularly), either 2 hours (n = 5) or 24 hours (n = 5) before the introduction of lipopolysaccharide. Middle ear fluid was sampled after 2, 4, and 6 hours of exposure.
  
  
  METHODS
  Middle ear fluid volume and albumin content were determined as measures of vascular extravasation. Histological sections of the middle ear mucosa were used to quantify the degree of leukocyte exudation. Data were analyzed by 1- or 2-way analysis of variance with the significance level set at P < .05.
  
  
  RESULTS
  Lipopolysaccharide exposure caused a significant increase in the mean +/- SEM middle ear fluid volume from 29.9 +/- 0.99 to 45.8 +/- 1.4 microL between the 2- and 6-hour samplings. Lipopolysaccharide exposure caused a significant increase in the albumin content of middle ear fluid from 70.1 +/- 19.2 to 271.0 +/- 93.1 micrograms between the 2- and 6-hour samplings. Both increases were significant compared with controls. Lipopolysaccharide also caused a significant increase in leukocytes localized to the middle ear mucosa. Pretreatment of animals with dexamethasone for either 2 or 24 hours inhibited the lipopolysaccharide-induced changes. There were no differences between 2- and 24-hour pretreatment with dexamethasone.
  
  
  CONCLUSIONS
  Dexamethasone inhibits the development of endotoxin-induced otitis media with effusion.
authors.affiliation: Department of Surgery, University of North Carolina School of Medicine, Chapel Hill, USA.
authors.forename: H C
authors.initials: HC
authors.lastname: Baggett
authors.forename: J
authors.initials: J
authors.lastname: Prazma
authors.forename: A S
authors.initials: AS
authors.lastname: Rose
authors.forename: A P
authors.initials: AP
authors.lastname: Lane
authors.forename: H C
authors.initials: HC
authors.lastname: Pillsbury
mesh_terms: D000418:Albumins / Q000378:metabolism; D000818:Animals; D003907:Dexamethasone / Q000494:pharmacology*; D005069:Evaluation Studies as Topic; D005122:Exudates and Transudates / Q000166:cytology / Q000378:metabolism; D005938:Glucocorticoids / Q000494:pharmacology*; D007962:Leukocytes; D008070:Lipopolysaccharides / Q000494:pharmacology; D010034:Otitis Media with Effusion / Q000188:drug therapy / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D000418:Albumins; D005938:Glucocorticoids; D008070:Lipopolysaccharides; D003907:Dexamethasone